; National Institutes of overall health; Bethesda, MD usAKeywords: adoptive immunotherapy, CD22, leukemia
; National Institutes of well being; Bethesda, MD usAKeywords: adoptive immunotherapy, CD22, leukemia, ALL, retroviral vectorsCD22 is definitely an desirable target for the development of immunotherapeutic approaches for the therapy…